Huennekens R Scott 4

What Happened
R. Scott Huennekens, a director of QuidelOrtho Corporation, had 6,829 restricted stock units (RSUs) vest on May 29, 2026 and those RSUs converted into 6,829 shares of common stock. The Form 4 reports an award/acquisition (code A) of 6,829 shares at $0.00 and a matching exercise/conversion of a derivative (code M) for 6,829 shares at $0.00 — reflecting release/settlement of RSUs with no cash paid.

Key Details

• Transaction date: May 29, 2026; Form 4 filed June 2, 2026.
• Reported entries: A — 6,829 shares @ $0.00 (acquired); M — 6,829 shares @ $0.00 (derivative conversion).
• Footnotes: F1 — release of RSUs previously reported; F2 — each RSU = one share; F3 — RSUs vested on May 29, 2026.
• Shares owned after transaction: not specified in the provided filing.
• Filing timeliness: Form filed June 2, 2026; no late-filing flag was indicated in the reported record.

Context
This was a routine equity-compensation event (RSU vesting and settlement), not an open-market purchase or sale. The M-code “disposition” here denotes conversion/settlement of the derivative (RSUs) into shares, not a public sale of stock. Such awards reflect compensation arrangements rather than an explicit insider buy or sell signal.